Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Stefoski

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Experientia|February 15, 1987
Selective blockade of components of potassium activation in Myxicola axonsM A Chuman, C L Schauf, F A Davis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1976
Correlation between diffuse EEG abnormalities and cerebral atrophy in senile dementiaD Stefoski, D Bergen, J Fox, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 1996
Myogenic and central neurogenic factors in fatigue in multiple sclerosisM Latash, E Kalugina, J Nicholas, et al.
Behaviour Research and Therapy|January 1, 1988
Toward a treatment logic for sleep apnea: the place of the tongue retaining deviceR Cartwright, D Stefoski, D Caldarelli, et al.
Neurology|August 1, 1982
Plasmapheresis decreases neuroelectric blocking activity in multiple sclerosisD Stefoski, C L Schauf, B C McLeod, et al.
AJR. American Journal of Roentgenology|March 4, 1999
Fluoroscopically guided percutaneous needle biopsy of the cervical spinal cordG Geremia, R Falter, D Stefoski, et al.
Neurology|May 1, 1985
Evaluation of cervical stimulation for chronic treatment of spasticityG L Gottlieb, B M Myklebust, D Stefoski, et al.
Neurology|September 1, 1991
4-Aminopyridine in multiple sclerosis: prolonged administrationD Stefoski, F A Davis, W E Fitzsimmons, et al.
European Journal of Neurology|January 26, 2016
Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing-remitting multiple sclerosisE-W Radue, T Sprenger, T Vollmer, et al.
Neurology|July 1, 1996
Validation of the functional assessment of multiple sclerosis quality of life instrumentD F Cella, K Dineen, B Arnason, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Experientia|February 15, 1987
Selective blockade of components of potassium activation in Myxicola axonsM A Chuman, C L Schauf, F A Davis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1976
Correlation between diffuse EEG abnormalities and cerebral atrophy in senile dementiaD Stefoski, D Bergen, J Fox, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 1996
Myogenic and central neurogenic factors in fatigue in multiple sclerosisM Latash, E Kalugina, J Nicholas, et al.
Behaviour Research and Therapy|January 1, 1988
Toward a treatment logic for sleep apnea: the place of the tongue retaining deviceR Cartwright, D Stefoski, D Caldarelli, et al.
Neurology|August 1, 1982
Plasmapheresis decreases neuroelectric blocking activity in multiple sclerosisD Stefoski, C L Schauf, B C McLeod, et al.
AJR. American Journal of Roentgenology|March 4, 1999
Fluoroscopically guided percutaneous needle biopsy of the cervical spinal cordG Geremia, R Falter, D Stefoski, et al.
Neurology|May 1, 1985
Evaluation of cervical stimulation for chronic treatment of spasticityG L Gottlieb, B M Myklebust, D Stefoski, et al.
Neurology|September 1, 1991
4-Aminopyridine in multiple sclerosis: prolonged administrationD Stefoski, F A Davis, W E Fitzsimmons, et al.
European Journal of Neurology|January 26, 2016
Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing-remitting multiple sclerosisE-W Radue, T Sprenger, T Vollmer, et al.
Neurology|July 1, 1996
Validation of the functional assessment of multiple sclerosis quality of life instrumentD F Cella, K Dineen, B Arnason, et al.
Pageof 3